Robert Hershberg has an estimated net worth of $4.68 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, RECURSION PHARMACEUTICALS, INC., NanoString Technologies Inc, FATE THERAPEUTICS INC, Silverback Therapeutics, Inc., HilleVax, Inc., DENDREON CORP, and Atai Beckley N.V..

2020 was Robert Hershberg's most active year for acquiring shares with 23 total transactions. Robert Hershberg's most active month to acquire stocks was the month of May. 2020 was Robert Hershberg's most active year for disposing of shares, totalling 50 transactions. Robert Hershberg's most active month to dispose stocks was the month of January. 2020 saw Robert Hershberg paying a total of $212,004.96 for 191,217 shares, this is the most they've acquired in one year. In 2020 Robert Hershberg cashed out on 125,226 shares for a total of $2,419,425.59, their largest year based on trade value.